Liu, X. I., Momper, J. D., Rakhmanina, N. Y., Green, D. J., Burckart, G. J., Cressey, T. R., . . . Dallmann, A. (2021). Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. Clinical pharmacokinetics, 60(6), 795-809. https://doi.org/10.1007/s40262-020-00977-w
Chicago Style (17th ed.) CitationLiu, Xiaomei I., et al. "Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir." Clinical Pharmacokinetics 60, no. 6 (2021): 795-809. https://doi.org/10.1007/s40262-020-00977-w.
MLA (9th ed.) CitationLiu, Xiaomei I., et al. "Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir." Clinical Pharmacokinetics, vol. 60, no. 6, 2021, pp. 795-809, https://doi.org/10.1007/s40262-020-00977-w.